Hepatitis B infection in patients with acute liver failure in the United States

E. K. Teo, G. Ostapowicz, M. Hussain, W. M. Lee, R. J. Fontana, A. S F Lok, W. Lee, A. Larson, C. Caldwell, M. Peters, L. Shick, N. Bass, T. Davern, S. Rouillard, E. Atillasoy, T. McCashland, J. E. Hay, R. Wiesner, J. Crippin, A. O. Shakil & 9 others A. Blie, S. Flamm, K. Benner, Paul Martin, P. Martin, Eugene R Schiff, E. Schiff, M. Torres, R. Fontana

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Occult hepatitis B virus (HBV) infection has been reported in 30% to 50% of patients with acute liver failure (ALF) in small case series. The aim of this study was to determine the prevalence of occult HBV infection in a large series of ALF patients in the United States and the prevalence of precore and core promoter variants in patients with ALF caused by hepatitis B. Sera from patients in the US ALF study and liver, when available, were tested using nested polymerase chain reaction (PCR) with primers in the HBV S and precore regions. PCR-positive samples were sequenced. Sera and/or liver from 139 patients (39 males, 100 females; mean age, 42 years) enrolled between January 1998 and December 1999 were studied. Twelve patients were diagnosed with hepatitis B, 1 with hepatitis B+C+D coinfection, and 22 had indeterminate etiology. HBV DNA was detected in the sera of 9 (6%) patients; all 9 had ALF caused by hepatitis B. HBV genotypes A, B, C, and D were present in 4, 3, 1, and 1 patients, respectively. Seven of these 9 patients had precore and/or core promoter variants. Liver from 19 patients were examined. HBV DNA was detected in the liver of 3 patients with ALF caused by hepatitis B, but in none of the remaining 16 patients with non-B ALF. Contrary to earlier reports, occult HBV infection was not present in this large series of ALF patients in the United States. HBV precore and/or core promoter variants were common among US patients with ALF caused by hepatitis B.

Original languageEnglish
Pages (from-to)972-976
Number of pages5
JournalHepatology
Volume33
Issue number4
DOIs
StatePublished - Apr 10 2001

Fingerprint

Acute Liver Failure
Hepatitis B
Hepatitis B virus
Infection
Virus Diseases
Liver
Serum
Cercopithecine Herpesvirus 1
Polymerase Chain Reaction
DNA
Hepatitis C
Coinfection

ASJC Scopus subject areas

  • Hepatology

Cite this

Teo, E. K., Ostapowicz, G., Hussain, M., Lee, W. M., Fontana, R. J., Lok, A. S. F., ... Fontana, R. (2001). Hepatitis B infection in patients with acute liver failure in the United States. Hepatology, 33(4), 972-976. https://doi.org/10.1053/jhep.2001.23065

Hepatitis B infection in patients with acute liver failure in the United States. / Teo, E. K.; Ostapowicz, G.; Hussain, M.; Lee, W. M.; Fontana, R. J.; Lok, A. S F; Lee, W.; Larson, A.; Caldwell, C.; Peters, M.; Shick, L.; Bass, N.; Davern, T.; Rouillard, S.; Atillasoy, E.; McCashland, T.; Hay, J. E.; Wiesner, R.; Crippin, J.; Shakil, A. O.; Blie, A.; Flamm, S.; Benner, K.; Martin, Paul; Martin, P.; Schiff, Eugene R; Schiff, E.; Torres, M.; Fontana, R.

In: Hepatology, Vol. 33, No. 4, 10.04.2001, p. 972-976.

Research output: Contribution to journalArticle

Teo, EK, Ostapowicz, G, Hussain, M, Lee, WM, Fontana, RJ, Lok, ASF, Lee, W, Larson, A, Caldwell, C, Peters, M, Shick, L, Bass, N, Davern, T, Rouillard, S, Atillasoy, E, McCashland, T, Hay, JE, Wiesner, R, Crippin, J, Shakil, AO, Blie, A, Flamm, S, Benner, K, Martin, P, Martin, P, Schiff, ER, Schiff, E, Torres, M & Fontana, R 2001, 'Hepatitis B infection in patients with acute liver failure in the United States', Hepatology, vol. 33, no. 4, pp. 972-976. https://doi.org/10.1053/jhep.2001.23065
Teo EK, Ostapowicz G, Hussain M, Lee WM, Fontana RJ, Lok ASF et al. Hepatitis B infection in patients with acute liver failure in the United States. Hepatology. 2001 Apr 10;33(4):972-976. https://doi.org/10.1053/jhep.2001.23065
Teo, E. K. ; Ostapowicz, G. ; Hussain, M. ; Lee, W. M. ; Fontana, R. J. ; Lok, A. S F ; Lee, W. ; Larson, A. ; Caldwell, C. ; Peters, M. ; Shick, L. ; Bass, N. ; Davern, T. ; Rouillard, S. ; Atillasoy, E. ; McCashland, T. ; Hay, J. E. ; Wiesner, R. ; Crippin, J. ; Shakil, A. O. ; Blie, A. ; Flamm, S. ; Benner, K. ; Martin, Paul ; Martin, P. ; Schiff, Eugene R ; Schiff, E. ; Torres, M. ; Fontana, R. / Hepatitis B infection in patients with acute liver failure in the United States. In: Hepatology. 2001 ; Vol. 33, No. 4. pp. 972-976.
@article{9a2f5c01241a46038bebf91cb8667f32,
title = "Hepatitis B infection in patients with acute liver failure in the United States",
abstract = "Occult hepatitis B virus (HBV) infection has been reported in 30{\%} to 50{\%} of patients with acute liver failure (ALF) in small case series. The aim of this study was to determine the prevalence of occult HBV infection in a large series of ALF patients in the United States and the prevalence of precore and core promoter variants in patients with ALF caused by hepatitis B. Sera from patients in the US ALF study and liver, when available, were tested using nested polymerase chain reaction (PCR) with primers in the HBV S and precore regions. PCR-positive samples were sequenced. Sera and/or liver from 139 patients (39 males, 100 females; mean age, 42 years) enrolled between January 1998 and December 1999 were studied. Twelve patients were diagnosed with hepatitis B, 1 with hepatitis B+C+D coinfection, and 22 had indeterminate etiology. HBV DNA was detected in the sera of 9 (6{\%}) patients; all 9 had ALF caused by hepatitis B. HBV genotypes A, B, C, and D were present in 4, 3, 1, and 1 patients, respectively. Seven of these 9 patients had precore and/or core promoter variants. Liver from 19 patients were examined. HBV DNA was detected in the liver of 3 patients with ALF caused by hepatitis B, but in none of the remaining 16 patients with non-B ALF. Contrary to earlier reports, occult HBV infection was not present in this large series of ALF patients in the United States. HBV precore and/or core promoter variants were common among US patients with ALF caused by hepatitis B.",
author = "Teo, {E. K.} and G. Ostapowicz and M. Hussain and Lee, {W. M.} and Fontana, {R. J.} and Lok, {A. S F} and W. Lee and A. Larson and C. Caldwell and M. Peters and L. Shick and N. Bass and T. Davern and S. Rouillard and E. Atillasoy and T. McCashland and Hay, {J. E.} and R. Wiesner and J. Crippin and Shakil, {A. O.} and A. Blie and S. Flamm and K. Benner and Paul Martin and P. Martin and Schiff, {Eugene R} and E. Schiff and M. Torres and R. Fontana",
year = "2001",
month = "4",
day = "10",
doi = "10.1053/jhep.2001.23065",
language = "English",
volume = "33",
pages = "972--976",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Hepatitis B infection in patients with acute liver failure in the United States

AU - Teo, E. K.

AU - Ostapowicz, G.

AU - Hussain, M.

AU - Lee, W. M.

AU - Fontana, R. J.

AU - Lok, A. S F

AU - Lee, W.

AU - Larson, A.

AU - Caldwell, C.

AU - Peters, M.

AU - Shick, L.

AU - Bass, N.

AU - Davern, T.

AU - Rouillard, S.

AU - Atillasoy, E.

AU - McCashland, T.

AU - Hay, J. E.

AU - Wiesner, R.

AU - Crippin, J.

AU - Shakil, A. O.

AU - Blie, A.

AU - Flamm, S.

AU - Benner, K.

AU - Martin, Paul

AU - Martin, P.

AU - Schiff, Eugene R

AU - Schiff, E.

AU - Torres, M.

AU - Fontana, R.

PY - 2001/4/10

Y1 - 2001/4/10

N2 - Occult hepatitis B virus (HBV) infection has been reported in 30% to 50% of patients with acute liver failure (ALF) in small case series. The aim of this study was to determine the prevalence of occult HBV infection in a large series of ALF patients in the United States and the prevalence of precore and core promoter variants in patients with ALF caused by hepatitis B. Sera from patients in the US ALF study and liver, when available, were tested using nested polymerase chain reaction (PCR) with primers in the HBV S and precore regions. PCR-positive samples were sequenced. Sera and/or liver from 139 patients (39 males, 100 females; mean age, 42 years) enrolled between January 1998 and December 1999 were studied. Twelve patients were diagnosed with hepatitis B, 1 with hepatitis B+C+D coinfection, and 22 had indeterminate etiology. HBV DNA was detected in the sera of 9 (6%) patients; all 9 had ALF caused by hepatitis B. HBV genotypes A, B, C, and D were present in 4, 3, 1, and 1 patients, respectively. Seven of these 9 patients had precore and/or core promoter variants. Liver from 19 patients were examined. HBV DNA was detected in the liver of 3 patients with ALF caused by hepatitis B, but in none of the remaining 16 patients with non-B ALF. Contrary to earlier reports, occult HBV infection was not present in this large series of ALF patients in the United States. HBV precore and/or core promoter variants were common among US patients with ALF caused by hepatitis B.

AB - Occult hepatitis B virus (HBV) infection has been reported in 30% to 50% of patients with acute liver failure (ALF) in small case series. The aim of this study was to determine the prevalence of occult HBV infection in a large series of ALF patients in the United States and the prevalence of precore and core promoter variants in patients with ALF caused by hepatitis B. Sera from patients in the US ALF study and liver, when available, were tested using nested polymerase chain reaction (PCR) with primers in the HBV S and precore regions. PCR-positive samples were sequenced. Sera and/or liver from 139 patients (39 males, 100 females; mean age, 42 years) enrolled between January 1998 and December 1999 were studied. Twelve patients were diagnosed with hepatitis B, 1 with hepatitis B+C+D coinfection, and 22 had indeterminate etiology. HBV DNA was detected in the sera of 9 (6%) patients; all 9 had ALF caused by hepatitis B. HBV genotypes A, B, C, and D were present in 4, 3, 1, and 1 patients, respectively. Seven of these 9 patients had precore and/or core promoter variants. Liver from 19 patients were examined. HBV DNA was detected in the liver of 3 patients with ALF caused by hepatitis B, but in none of the remaining 16 patients with non-B ALF. Contrary to earlier reports, occult HBV infection was not present in this large series of ALF patients in the United States. HBV precore and/or core promoter variants were common among US patients with ALF caused by hepatitis B.

UR - http://www.scopus.com/inward/record.url?scp=17744387699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744387699&partnerID=8YFLogxK

U2 - 10.1053/jhep.2001.23065

DO - 10.1053/jhep.2001.23065

M3 - Article

VL - 33

SP - 972

EP - 976

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4

ER -